MERLIN: Two-Year Results of Brolucizumab in Participants with Neovascular Age-Related Macular Degeneration and Persistent Retinal Fluid.

Autor: Brown DM; Retina Consultants of Texas, Retina Consultants of America, Houston, Texas; Blanton Eye Institute, Houston Methodist Hospital, Houston, Texas., Jaffe GJ; Department of Ophthalmology, Duke University, Durham, North Carolina., Wykoff CC; Retina Consultants of Texas, Retina Consultants of America, Houston, Texas; Blanton Eye Institute, Houston Methodist Hospital, Houston, Texas., Adiguzel E; Novartis Pharmaceuticals, East Hanover, New Jersey., Heier JS; Ophthalmic Consultants of Boston, Boston, Massachusetts., Khanani AM; Sierra Eye Associates, Reno, Nevada; University of Nevada, Reno School of Medicine, Reno, Nevada. Electronic address: arshad.khanani@gmail.com.

Publikováno v: Ophthalmology [Ophthalmology] 2024 Sep 07. Date of Electronic Publication: 2024 Sep 07.

Real-World Safety Outcomes with Brolucizumab in Neovascular Age-Related Macular Degeneration: Findings from the IRIS® Registry.

Autor: Zarbin MA; Department of Ophthalmology and Visual Science, Rutgers New Jersey Medical School, Rutgers University, 90 Bergen Street, Room 6155, Newark, NJ, 07103, USA. zarbin@njms.rutgers.edu., MacCumber MW; Department of Ophthalmology, Rush University Medical Center, Chicago, IL, USA.; Illinois Retina Associates, Chicago, IL, USA., Karcher H; Novartis Pharma AG, Basel, Switzerland., Adiguzel E; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA., Mayhook A; Oxford PharmaGenesis, Oxford, UK., LaPrise A; Verana Health, Inc., San Francisco, CA, USA., Bilano VL; Novartis Pharmaceuticals UK Ltd, London, UK., Igwe F; Novartis Pharma AG, Basel, Switzerland., Ip MS; Doheny Eye Institute, University of California, Los Angeles, CA, USA., Wykoff CC; Retina Consultants of Texas, Houston, TX, USA.; Blanton Eye Institute, Houston Methodist Hospital, Houston, TX, USA.

Publikováno v: Ophthalmology and therapy [Ophthalmol Ther] 2024 May; Vol. 13 (5), pp. 1357-1368. Date of Electronic Publication: 2024 Mar 23.

Best Practice Recommendations for Dysphagia Management in Intensive Care Unit (ICU): A Delphi Study from Multidisciplinary Experts in Turkey.

Autor: Umay E; Ankara Etlik City Physical Medicine and Rehabilitation Hospital, University of Health Sciences Turkey, Halil Sezai Erkut Street, No. 5, 06170, Yenimahalle, Ankara, Turkey. ebruumay@gmail.com., Eyigor S; Department of Physical Medicine and Rehabilitation, Ege University, Izmir, Turkey., Demirag K; Department of Anesthesiology and Reanimation, Ege University, Izmir, Turkey., Kaymak Karatas G; Department of Physical Medicine and Rehabilitation, Gazi University, Ankara, Turkey., Gundogdu I; Ankara Etlik City Physical Medicine and Rehabilitation Hospital, University of Health Sciences Turkey, Halil Sezai Erkut Street, No. 5, 06170, Yenimahalle, Ankara, Turkey., Giray E; Department of Physical Medicine and Rehabilitation, Fatih Sultan Mehmet Training and Research Hospital, University of Health Sciences Turkey, Istanbul, Turkey., Panpalli Ates M; Department of Neurology, Ankara Etlik City Hospital, University of Health Sciences Turkey, Ankara, Turkey., Gonenli Kocer B; Department of Neurology, Ankara Etlik City Hospital, University of Health Sciences Turkey, Ankara, Turkey., Gurcay E; Gaziler Physical Medicine and Rehabilitation Training and Research Hospital, University of Health Sciences Turkey, Ankara, Turkey., Unlu Z; Department of Physical Medicine and Rehabilitation, Celal Bayar University, Manisa, Turkey., Bengisu S; Department of Speech and Language Therapy, Fenerbahce University, Istanbul, Turkey., Karaahmet F; Department of Gastroenterology, Medicana International Ankara Hospital, Ankara, Turkey., Bagcier F; Department of Physical Medicine and Rehabilitation, Basaksehir Cam Sakura Hospital, Istanbul, Turkey., Vural M; Department of Physical Medicine and Rehabilitation, Bakırköy Dr. Sadi Konuk Training and Research Hospital, University of Health Sciences, Istanbul, Turkey., Aydeniz B; Department of Physical Medicine and Rehabilitation, Bakırköy Dr. Sadi Konuk Training and Research Hospital, University of Health Sciences, Istanbul, Turkey., Kullukcu H; Department of Neurosurgery, Ankara Medical Park Hospital, Ankara, Turkey., Oztekin F; Department of Neurology, Ankara Etlik City Hospital, University of Health Sciences Turkey, Ankara, Turkey., Alicura S; Department of Otolaryngology, Head and Neck Surgery, Ankara Etlik City Hospital, University of Health Sciences Turkey, Ankara, Turkey., Uz C; Ankara Etlik City Physical Medicine and Rehabilitation Hospital, University of Health Sciences Turkey, Halil Sezai Erkut Street, No. 5, 06170, Yenimahalle, Ankara, Turkey., Barmak E; Department of Speech and Language Therapy, Ankara Etlik City Hospital, University of Health Sciences Turkey, Ankara, Turkey., Uzunkulaoglu A; Ankara Etlik City Physical Medicine and Rehabilitation Hospital, University of Health Sciences Turkey, Halil Sezai Erkut Street, No. 5, 06170, Yenimahalle, Ankara, Turkey., Adiguzel E; Ankara Etlik City Physical Medicine and Rehabilitation Hospital, University of Health Sciences Turkey, Halil Sezai Erkut Street, No. 5, 06170, Yenimahalle, Ankara, Turkey.

Publikováno v: Dysphagia [Dysphagia] 2024 Apr; Vol. 39 (2), pp. 241-254. Date of Electronic Publication: 2023 Aug 05.

The mesocortical dopaminergic system cannot explain hyperactivity in an animal model of attention deficit hyperactivity disorder (ADHD)- Spontaneously hypertensive rats (SHR).

Autor: Gungor Aydin A; Department of Psychology, Rutgers University-New Brunswick, Piscataway, NJ, 08854, USA. aysegul.ga@rutgers.edu., Adiguzel E; Department of Anatomy, Faculty of Medicine, Pamukkale University, 20070, Denizli, Turkey.; Department of Neuroscience, Institute of Health Sciences, Pamukkale University, 20070, Denizli, Turkey.

Publikováno v: Laboratory animal research [Lab Anim Res] 2023 Sep 14; Vol. 39 (1), pp. 20. Date of Electronic Publication: 2023 Sep 14.

Factors Linked to Injection Interval Extension in Eyes with Wet Age-Related Macular Degeneration Switched to Brolucizumab.

Autor: MacCumber MW; Department of Ophthalmology, Rush University Medical Center and Illinois Retina Associates, Chicago, Illinois. Electronic address: mmaccumber@illinoisretina.com., Wykoff CC; Retinal Consultants of Texas, Houston, Texas., Karcher H; Novartis Pharma AG, Basel, Switzerland., Adiguzel E; Novartis Pharmaceuticals Corp., East Hanover, New Jersey., Sinha SB; Sandoz, a Novartis Division, Basel, Switzerland., Vishwakarma S; Verana Health, Inc., San Francisco, California., LaPrise A; Verana Health, Inc., San Francisco, California., Igwe F; Novartis Pharma AG, Basel, Switzerland., Freitas R; Novartis Farma-Produtos Farmacêuticos S.A., Porto Salvo, Portugal., Ip MS; Doheny Eye Institute, University of California, Los Angeles, Los Angeles, California., Zarbin MA; Institute of Ophthalmology and Visual Science, Rutgers New Jersey Medical School, Newark, New Jersey.

Publikováno v: Ophthalmology [Ophthalmology] 2023 Aug; Vol. 130 (8), pp. 795-803. Date of Electronic Publication: 2023 Mar 27.